Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.
2.

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.

Cicero AF, Derosa G, Pisciotta L, Barbagallo C; SISA-PUFACOL Study Group..

J Med Food. 2015 Nov;18(11):1270-3. doi: 10.1089/jmf.2015.0024. Epub 2015 Aug 14.

3.

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.

Hing Ling PK, Civeira F, Dan AG, Hanson ME, Massaad R, De Tilleghem Cle B, Milardo C, Triscari J.

Lipids Health Dis. 2012 Jan 31;11:18. doi: 10.1186/1476-511X-11-18.

6.

Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage ME, Musliner TA, Cohen JC, Hobbs HH.

J Clin Endocrinol Metab. 2010 Feb;95(2):800-9. doi: 10.1210/jc.2009-1952. Epub 2009 Dec 4. Erratum in: J Clin Endocrinol Metab. 2011 May;96(5):1582.

7.

Supplemental Content

Loading ...
Support Center